Matches in SemOpenAlex for { <https://semopenalex.org/work/W2745855008> ?p ?o ?g. }
- W2745855008 endingPage "226" @default.
- W2745855008 startingPage "161" @default.
- W2745855008 abstract "In May 2003, the US Food and Drug Administration (FDA) granted accelerated approval for the use of the first-in-class proteasome inhibitor bortezomib as a third-line therapy in multiple myeloma, and the European Union followed suit a year later. Bortezomib has subsequently been approved for multiple myeloma as a second-line treatment on its own and as a first-line therapy in combination with an alkylating agent and a corticosteroid. Furthermore, bortezomib has also been approved as a second-line therapy for mantle cell lymphoma. In this chapter, the focus is on the current clinical research on bortezomib, its adverse effects, and the resistance of multiple myeloma patients to bortezomib-based therapy. The various applications of bortezomib in different diseases and recent advances in the development of a new generation of inhibitors that target the proteasome or other parts of the ubiquitin-proteasome system are also reviewed." @default.
- W2745855008 created "2017-08-31" @default.
- W2745855008 creator A5059718852 @default.
- W2745855008 date "2012-01-01" @default.
- W2745855008 modified "2023-09-25" @default.
- W2745855008 title "Proteasome Inhibitors" @default.
- W2745855008 cites W1497973518 @default.
- W2745855008 cites W1515942294 @default.
- W2745855008 cites W1540671296 @default.
- W2745855008 cites W1545814905 @default.
- W2745855008 cites W1595109869 @default.
- W2745855008 cites W1603251764 @default.
- W2745855008 cites W1612177578 @default.
- W2745855008 cites W1620831616 @default.
- W2745855008 cites W176199101 @default.
- W2745855008 cites W1956445565 @default.
- W2745855008 cites W1964602059 @default.
- W2745855008 cites W1964963501 @default.
- W2745855008 cites W1965344560 @default.
- W2745855008 cites W1966740033 @default.
- W2745855008 cites W1968557197 @default.
- W2745855008 cites W1970158990 @default.
- W2745855008 cites W1970349229 @default.
- W2745855008 cites W1970430170 @default.
- W2745855008 cites W1970599858 @default.
- W2745855008 cites W1972676790 @default.
- W2745855008 cites W1973140160 @default.
- W2745855008 cites W1974010669 @default.
- W2745855008 cites W1975305152 @default.
- W2745855008 cites W1975396841 @default.
- W2745855008 cites W1976015013 @default.
- W2745855008 cites W1978032094 @default.
- W2745855008 cites W1979388707 @default.
- W2745855008 cites W1980714008 @default.
- W2745855008 cites W1981472752 @default.
- W2745855008 cites W1981479881 @default.
- W2745855008 cites W1981513493 @default.
- W2745855008 cites W1981889346 @default.
- W2745855008 cites W1982981861 @default.
- W2745855008 cites W1983202503 @default.
- W2745855008 cites W1983706317 @default.
- W2745855008 cites W1985275612 @default.
- W2745855008 cites W1985343909 @default.
- W2745855008 cites W1986036865 @default.
- W2745855008 cites W1986329393 @default.
- W2745855008 cites W1987583882 @default.
- W2745855008 cites W1988721974 @default.
- W2745855008 cites W1989569525 @default.
- W2745855008 cites W1989604393 @default.
- W2745855008 cites W1989734946 @default.
- W2745855008 cites W1989740966 @default.
- W2745855008 cites W1990594693 @default.
- W2745855008 cites W1991341595 @default.
- W2745855008 cites W1991485215 @default.
- W2745855008 cites W1992978957 @default.
- W2745855008 cites W1993435599 @default.
- W2745855008 cites W1993801059 @default.
- W2745855008 cites W1994016697 @default.
- W2745855008 cites W1994412772 @default.
- W2745855008 cites W1996934444 @default.
- W2745855008 cites W1997020184 @default.
- W2745855008 cites W1997503058 @default.
- W2745855008 cites W1998297722 @default.
- W2745855008 cites W1999293059 @default.
- W2745855008 cites W2000044224 @default.
- W2745855008 cites W2000781567 @default.
- W2745855008 cites W2001160758 @default.
- W2745855008 cites W2007644267 @default.
- W2745855008 cites W2010163650 @default.
- W2745855008 cites W2010184965 @default.
- W2745855008 cites W2010553151 @default.
- W2745855008 cites W2010818204 @default.
- W2745855008 cites W2011372640 @default.
- W2745855008 cites W2013087695 @default.
- W2745855008 cites W2013660816 @default.
- W2745855008 cites W2015508817 @default.
- W2745855008 cites W2016098671 @default.
- W2745855008 cites W2016381720 @default.
- W2745855008 cites W2016742872 @default.
- W2745855008 cites W2017303578 @default.
- W2745855008 cites W2017767848 @default.
- W2745855008 cites W2018006390 @default.
- W2745855008 cites W2019543614 @default.
- W2745855008 cites W2020031294 @default.
- W2745855008 cites W2021811511 @default.
- W2745855008 cites W2022002157 @default.
- W2745855008 cites W2022894667 @default.
- W2745855008 cites W2023501070 @default.
- W2745855008 cites W2023965930 @default.
- W2745855008 cites W2024691762 @default.
- W2745855008 cites W2025389621 @default.
- W2745855008 cites W2025839879 @default.
- W2745855008 cites W2027698567 @default.
- W2745855008 cites W2027708097 @default.
- W2745855008 cites W2029006246 @default.
- W2745855008 cites W2029501972 @default.
- W2745855008 cites W2030625864 @default.
- W2745855008 cites W2030628715 @default.